pillbase.ru

Kisplyx

Active substance: lenvatinib

lenvatinib mesilate

Centralised EU authorisationActive

Marketing holder: Eisai GmbH

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 8
  • Lenvima
    CAPSULE · LENVATINIB 4 mg/1
    62856-704
    Eisai Inc.
  • Lenvima
    CAPSULE · LENVATINIB 10 mg/1
    62856-710
    Eisai Inc.
  • Lenvima
    CAPSULE · LENVATINIB 4 mg/1
    62856-712
    Eisai Inc.
  • Lenvima
    KIT · lenvatinib
    62856-724
    Eisai Inc.
  • Lenvima
    KIT · lenvatinib
    62856-714
    Eisai Inc.
All products in this country (8)
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-8b71-72db-bee4-0f31fe4dde31,01a12092-2433-76a8-b5b7-e4465e775ab3,01a12094-0a6f-7a75-bb49-f8516af7c796,01a12094-0a75-7ecd-8e55-885c8d0bb893,01a12098-f921-70a2-b951-4b83f36a174c;count=8 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004224
Registration status
Active
ATC code
L01XE29
Sources
  • product · EMA · EMEA/H/C/004224 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004224 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004224 · Verified 2026-10-09